463 related articles for article (PubMed ID: 27186356)
21. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
22. Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.
Aulinger BA; Bedorf A; Kutscherauer G; de Heer J; Holst JJ; Göke B; Schirra J
Diabetes; 2014 Mar; 63(3):1079-92. PubMed ID: 24296715
[TBL] [Abstract][Full Text] [Related]
23. Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.
Kim SH; Abbasi F; Nachmanoff C; Stefanakis K; Kumar A; Kalra B; Savjani G; Mantzoros CS
Diabetes Obes Metab; 2021 Feb; 23(2):489-498. PubMed ID: 33140542
[TBL] [Abstract][Full Text] [Related]
24. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans.
Vahl TP; Paty BW; Fuller BD; Prigeon RL; D'Alessio DA
J Clin Endocrinol Metab; 2003 Apr; 88(4):1772-9. PubMed ID: 12679472
[TBL] [Abstract][Full Text] [Related]
25. β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy.
Garibay D; McGavigan AK; Lee SA; Ficorilli JV; Cox AL; Michael MD; Sloop KW; Cummings BP
Endocrinology; 2016 Sep; 157(9):3405-9. PubMed ID: 27501183
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism.
Nakashima K; Kaneto H; Shimoda M; Kimura T; Kaku K
Sci Rep; 2018 Feb; 8(1):3725. PubMed ID: 29487355
[TBL] [Abstract][Full Text] [Related]
27. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
28. [Incretin and bone].
Yamada Y
Clin Calcium; 2009 Sep; 19(9):1312-7. PubMed ID: 19721203
[TBL] [Abstract][Full Text] [Related]
29. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.
Gu W; Winters KA; Motani AS; Komorowski R; Zhang Y; Liu Q; Wu X; Rulifson IC; Sivits G; Graham M; Yan H; Wang P; Moore S; Meng T; Lindberg RA; Véniant MM
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E624-32. PubMed ID: 20647556
[TBL] [Abstract][Full Text] [Related]
30. Updating the Role of α-Cell Preproglucagon Products on GLP-1 Receptor-Mediated Insulin Secretion.
Sandoval D
Diabetes; 2020 Nov; 69(11):2238-2245. PubMed ID: 33082272
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.
Smits MM; Tonneijck L; Muskiet MH; Kramer MH; Cahen DL; van Raalte DH
Diabetes Obes Metab; 2016 Mar; 18(3):224-35. PubMed ID: 26500045
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis.
Traub S; Meier DT; Schulze F; Dror E; Nordmann TM; Goetz N; Koch N; Dalmas E; Stawiski M; Makshana V; Thorel F; Herrera PL; Böni-Schnetzler M; Donath MY
Cell Rep; 2017 Mar; 18(13):3192-3203. PubMed ID: 28355570
[TBL] [Abstract][Full Text] [Related]
34. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
Yabe D; Seino Y
Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
[TBL] [Abstract][Full Text] [Related]
35. Insulin Secretion Depends on Intra-islet Glucagon Signaling.
Svendsen B; Larsen O; Gabe MBN; Christiansen CB; Rosenkilde MM; Drucker DJ; Holst JJ
Cell Rep; 2018 Oct; 25(5):1127-1134.e2. PubMed ID: 30380405
[TBL] [Abstract][Full Text] [Related]
36. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Salehi M; Vahl TP; D'Alessio DA
J Clin Endocrinol Metab; 2008 Dec; 93(12):4909-16. PubMed ID: 18827000
[TBL] [Abstract][Full Text] [Related]
37. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas.
Heller RS; Kieffer TJ; Habener JF
Diabetes; 1997 May; 46(5):785-91. PubMed ID: 9133545
[TBL] [Abstract][Full Text] [Related]
38. Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia.
Vahl TP; Aulinger BA; Smith EP; Drazen DL; Ulrich-Lai Y; Seeley RJ; Woods SC; D'Alessio DA
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E784-92. PubMed ID: 25159330
[TBL] [Abstract][Full Text] [Related]
39. Is glucagon-like peptide 1 an incretin hormone?
Nauck MA
Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
[TBL] [Abstract][Full Text] [Related]
40. Expression of glucagon-like peptide-1 receptor and glucose‑dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells.
Aoyama E; Watari I; Podyma-Inoue KA; Yanagishita M; Ono T
Int J Mol Med; 2014 Aug; 34(2):475-82. PubMed ID: 24866833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
